Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.2 (
PDK1
)
2,238
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PDK
-1 activates PI3-kinase/Akt signaling and regulates fundamental cellular functions, such as growth and survival. NF-kB is involved in the induction of a variety of cellular genes affecting immunity, inflammation and the resistance to apoptosis induced by some anti-cancer drugs. Even though the crucial involvement of the PI3-kinase/Akt pathway in the anti-apoptotic activation of NF-kB is well known, the exact role of
PDK
-1 as well as PI3-kinase/Akt in NF-kB activation is not understood. Here we demonstrate that
PDK
-1 plays a pivotal role in transcriptional activation of NF-kB by dissociating the transcriptional co-repressor HDAC1 from the p65 subunit of NF-kB. The association of CBP with p65 was not directly modulated by
PDK
-1 or by PI3-kinase.
Etoposide
activated NF-kB through PI3-kinase/Akt, and the transcription activation domain (TAD) of p65 was further activated by wild-type
PDK
-1. Overexpression of a dominant negative
PDK
-1 mutant decreased etoposide-induced NF-kB transcription and further down-regulated the ectopic HDAC1-mediated decrease in NF-kB transcriptional activity. Thus activation of
PDK
-1 relieves the HDAC1-mediated repression of NF-kB that may be related to basal as well as activated transcription by NF-kB. This effect may also explain the role of the PI3-kinase/
PDK
-1 pathway in the anti-apoptotic function of NF-kB associated with the chemoresistance of cancer cells.
...
PMID:PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. 1626 99